Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:42:52.473Z.
Calculation as of: 2026-10-06T15:42:52.473Z.
Quote observation: 2026-10-06T15:40:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 82cee4a6010f8650e239c44e6fa86f6cad5a1cacb0b867e980d6d40a64789328
EARNINGS YIELD
N/A
Nautilus Biotechnolgy, Inc.
Market Cap
$249.33M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$246.89M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.60M
Earnings Yield
N/A
TTM Avg
2.23%
3Y Avg
2.23%
5Y Avg
2.23%
Market Cap
$254.41M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.34M
Earnings Yield
N/A
TTM Avg
37.01%
3Y Avg
37.01%
5Y Avg
37.01%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $249.33M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $247.23M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $248.53M | 33.41% | 26.39% | 26.39% | 30.90% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.89M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $252.22M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.60M | N/A | 2.23% | 2.23% | 2.23% |
| Century Therapeutics, Inc. (IPSC)vs › | $254.41M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.34M | N/A | 37.01% | 37.01% | 37.01% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $241.89M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $240.82M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
